piribedil has been researched along with Catatonic Rigidity in 2 studies
Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marusiak, J | 1 |
| Jaskólska, A | 1 |
| Koszewicz, M | 1 |
| Budrewicz, S | 1 |
| Jaskólski, A | 1 |
| Engel, J | 1 |
| Granerus, AK | 1 |
| Svanborg, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects of Myofascial Trigger Points Therapy in Migraine.[NCT05646160] | 100 participants (Anticipated) | Interventional | 2018-01-15 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for piribedil and Catatonic Rigidity
| Article | Year |
|---|---|
Myometry revealed medication-induced decrease in resting skeletal muscle stiffness in Parkinson's disease patients.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Body Mass Index; Electromyography; Female; Humans; In | 2012 |
Piribedil in Parkinson's syndrome: a clinical study.
Topics: Activities of Daily Living; Aged; Alkaline Phosphatase; Brain Diseases; Dose-Response Relationship, | 1975 |